A Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma
Clinical trial NCT06019637 · RECRUITING
Trial details
- NCT number
- NCT06019637
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-22
- Primary completion
- 2038-09-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.